-
Positive results from new triple combinations in Cystic Fibrosis, displayed by Vertex
- October 21, 2018
- Posted by: PharmaScroll
- Category:
No Comments -
Vertex Initiates Phase 3 Studies of VX-445, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis
- April 30, 2018
- Posted by: PharmaScroll
- Category: